Not applicableStudy completedNCT04046731What this trial is testingNeuromuscular Blocking Agents Utilized During Perioperative Hypersensitivity EvaluationWho this might be right forAllergy Mayo Clinic 187
Not applicableLooking for participantsNCT07444801What this trial is testingIntervention With Tralokinumab in Patients With Moderate-to-severe Atopic Dermatitis With Genital ImpactWho this might be right forAtopic Dermatitis (Moderate-to-severe) Involving the Genital Region University Hospital Schleswig-Holstein 30
Not applicableNot Yet RecruitingNCT07642557What this trial is testingRemibrutinib in Real-world Clinical Practice - a Germany Sub-study (REASSERT)Who this might be right forChronic Spontaneous Urticaria Novartis Pharmaceuticals 470
Not applicableStudy completedNCT02773095What this trial is testingEvaluation of Novartis Access; a Non-communicable Disease (NCD) Access InitiativeWho this might be right forCardiovascular DiseaseDiabetes Type IIBreast Cancer+1 more Boston University 966
Not applicableStudy completedNCT00806364What this trial is testingNormal Blood, Bone Marrow and Buccal Mucosa ProtocolWho this might be right forNon-atopicAtopicHealthy+2 more National Institute of Allergy and Infectious Diseases (NIAID) 119
Large-scale testing (Phase 3)Study completedNCT04206605What this trial is testingLanadelumab in Teenagers and Adults to Prevent Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH)Who this might be right forAngioedema Takeda 77
Post-approval studies (Phase 4)Ended earlyNCT00363688What this trial is testingTreating Patients With a History of Non-Life Threatening Allergic Reaction to Penicillin With PenicillinWho this might be right forPenicillin Allergy Meir Medical Center
Not applicableEnded earlyNCT00949052What this trial is testingGenetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for CancerWho this might be right forCancer Vanderbilt-Ingram Cancer Center 1,000
Not applicableWithdrawnNCT04985357What this trial is testingDefining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to DrugsWho this might be right forStage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more Travera Inc
Not applicableNo Longer AvailableNCT04583007What this trial is testingExpanded Access for the Prevention of Acute Attacks of 1) Hereditary Angioedema (HAE) in Children and 2) Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH) in Teenagers and AdultsWho this might be right forHereditary Angioedema (HAE)Angioedema Shire
Not applicableStudy completedNCT04130191What this trial is testingLanadelumab in Persons With Hereditary Angioedema (HAE) Type I or IIWho this might be right forHereditary Angioedema (HAE) Shire 140
Testing effectiveness (Phase 2)Study completedNCT00560326What this trial is testingTacrolimus Ointment Long Term Safety in Young Children With Atopic DermatitisWho this might be right forDermatitis, Atopic Astellas Pharma Inc 50
Not applicableActive Not RecruitingNCT03849716What this trial is testingEvaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients (PEDISTAD BIOMARKER STUDY)Who this might be right forDermatitis Atopic Sanofi 266
Large-scale testing (Phase 3)UnknownNCT04398758What this trial is testingMoisturizer Mediated Prevention of Symptoms of Atopic Dermatitis in Early ChildhoodWho this might be right forAtopic DermatitisInfant, Newborn Infectopharm Arzneimittel GmbH 360
Not applicableUnknownNCT06127992What this trial is testingNon-invasive Diagnosis of Cold UrticariaWho this might be right forUrticaria Cold City Clinical Hospital No.52 of Moscow Healthcare Department 78
Large-scale testing (Phase 3)Study completedNCT03428100What this trial is testingA Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine or for Those Who Cannot Take Oral Cyclosporine Because it is Not Medically AdvisableWho this might be right forAtopic Dermatitis Eli Lilly and Company 463
Testing effectiveness (Phase 2)Ended earlyNCT03736967What this trial is testingEfficacy and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic DermatitisWho this might be right forAtopic Dermatitis Regeneron Pharmaceuticals 206
Not applicableStudy completedNCT03324919What this trial is testingPatient Centered Care Situation and Health-related Quality of Life by Patients With Psoriasis, Urticaria or LupusWho this might be right forQuality of Life University Hospital Regensburg 220
Not applicableStudy completedNCT05824637What this trial is testingValidation and Reproducibility of S.P.A.T. With AllergensWho this might be right forAllergy to House DustAllergy Pollen Hippocreates 112
Post-approval studies (Phase 4)Study completedNCT02550106What this trial is testingOmalizumab in Chronic Spontaneous Urticaria Patients Non Responding to Initial Standard antihistaminE TreatmentWho this might be right forCHRONIC SPONTANEOUS URTICARIA Novartis Pharmaceuticals 136